- Previous Close
6.78 - Open
6.75 - Bid 6.24 x 100
- Ask 7.13 x 100
- Day's Range
6.22 - 6.75 - 52 Week Range
5.30 - 36.52 - Volume
18,384 - Avg. Volume
72,163 - Market Cap (intraday)
640.791M - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
11.74 - EPS (TTM)
0.53 - Earnings Date Nov 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.00
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
sbc-holdings.com1,639
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBC
View MorePerformance Overview: SBC
Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBC
View MoreValuation Measures
Market Cap
640.79M
Enterprise Value
531.67M
Trailing P/E
11.78
Forward P/E
0.59
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.87
Price/Book (mrq)
3.13
Enterprise Value/Revenue
2.38
Enterprise Value/EBITDA
5.51
Financial Highlights
Profitability and Income Statement
Profit Margin
27.55%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
217.54M
Net Income Avi to Common (ttm)
59.94M
Diluted EPS (ttm)
0.53
Balance Sheet and Cash Flow
Total Cash (mrq)
103.7M
Total Debt/Equity (mrq)
18.35%
Levered Free Cash Flow (ttm)
--